Coronavirus (COVID-19)

This page contains medical information for clinicians on the 2019 Novel Coronavirus (COVID-19, also called 2019-nCoV, and now clinically SARS‐CoV‐2). This section includes articles that pertain to clinicians and cardiologists on the virus, new technologies being deployed to fight the virus and clinical information from various sources. Here are direct links for medical professionals to COVID-19 resources from the U.S. Food and Drug Administration (FDA)Centers for Disease Control (CDC) and the World Health Organization (WHO). Daily world-wide statistics on the coronavirus outbreak are available from the WHO Situations Reports. Here is the Centers for Medicare and Medicaid Services (CMS) frequently asked questions and answers (FAQs) for healthcare providers regarding Medicare payment for laboratory tests and other services related to the COVID-19.

Videos | Coronavirus (COVID-19)

Payam Dehghani, M.D.,  FRCPC, FACC, FSCAI, co-director of Prairie Vascular Research and associate professor at the ...

Home May 06, 2021
Home
One third of patients will die who have COVID-19 (SARS-CoV-2) and suffer a ST-elevated myocardial infarction (STEMI), according to the latest, comprehensive data from The North American COVID-19 Myocardial Infarction (NACMI) Registry. The data was presented as a late-breaking study at the Society for Cardiovascular Angiography and Interventions (SCAI) 2021 Scientific Sessions. The study showed there was an alarming one-in-three patients dying with STEMI and COVID, compared to 4-in-100 #SCAI2021
Feature | Coronavirus (COVID-19) | By Dave Fornell, Editor

May 3, 2021 – One third of patients will die who have COVID-19 (SARS-CoV-2) and suffer a ST-elevated myocardial ...

Home May 03, 2021
Home
News | Cath Lab

April 28, 2021 – Results from a retrospective observational study, presented today at Society for Cardiovascular ...

Home April 28, 2021
Home
News

April 20, 2021 – The Minneapolis Heart Institute Foundation (MHIF) announced the first publication of outcomes from the ...

Home April 20, 2021
Home
CDC and FDA Call for Pause on Janssen COVID-19 Vaccine Due to Rare Blood Clots #COVID19 #Janssen
Feature | Coronavirus (COVID-19) | By Dave Fornell, Editor

(This story was updated May 7, 2021 in the last subheaded section)


April 13, 2021 — The U.S. Food and Drug ...

Home April 13, 2021
Home
News | Coronavirus (COVID-19)

April 6, 2021 — A tsunami of chronic health conditions as a result of the COVID-19 (SARS-CoV-2) pandemic, especially car ...

Home April 07, 2021
Home
Videos | Coronavirus (COVID-19)

Behnood Bikdeli M.D., a cardiologist at the Brigham and Women’s Hospital, Harvard Medical School, Boston, offers an ...

Home April 01, 2021
Home
Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) can potentiate all 3 sides of Virchow’s Triad of coagulopathy, including endothelial dysfunction, blood flow stasis, and hypercoagulability. Angiotensin-converting enzyme-2 (ACE-2)–dependent viral entry and the virus-induced inflammatory response can lead to endothelial dysfunction. Clotting Prevention in COVID-19 Patients, Thrombosis Prevention in COVID-19 Patients, Preventing blood clots in COVID-19 patients
Feature | Antiplatelet and Anticoagulation Therapies | By Dave Fornell, Editor

A comprehensive review or more than 80 randomized controlled trials (RCTs) investigating how to best manage optimal ...

Home March 22, 2021
Home
News | Coronavirus (COVID-19)

March 17, 2021 — Around 50% of patients who have been hospitalized with severe COVID-19 (SARS-CoV-2) and have damage to ...

Home March 17, 2021
Home
A study from Washington University School of Medicine in St. Louis provides evidence that the coronavirus can invade and replicate inside heart muscle cells, causing cell death and interfering with heart muscle contraction. The image of engineered heart tissue shows human heart muscle cells (red) infected with COVID-19 (SARS-CoV-2) (green). Image by Lina Greenberg.
Feature | Coronavirus (COVID-19)

March 12, 2021 — Since early in the pandemic, COVID-19 has been associated with heart problems, including reduced ...

Home March 12, 2021
Home
News | Coronavirus (COVID-19)

March 12, 2021 — A new review suggests that blood vessel damage and impaired oxygen delivery related to COVID-19 play a ...

Home March 12, 2021
Home
AMERICAN COLLEGE OF CARDIOLOGY (ACC) Late-breaking clinical trial study presentations at ACC.21. @ACC21 @ACC2021
Feature | ACC | Dave Fornell, Editor

The latest cardiology practice-changing scientific breakthrough, late-breaking study presentations have been announced ...

Home May 18, 2021
Home
The two biggest cardiac device technology stories in February included the Boston Scientific recall of its S-ICD system, and the FDA clearance of the Shockwave intravascular lithotripsy system to break up calcified lesions in the coronary arteries.
Feature | By Dave Fornell, Editor

March 1, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

Home March 01, 2021
Home
News | Coronavirus (COVID-19)

March 1, 2021 — The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for the third ...

Home March 01, 2021
Home
Subscribe Now